2015-2025 Global Metabolic Disorders Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

July 2024 | 108 pages | ID: 29A9EC7987E3EN
99Strategy

Abstracts

SUMMARY

The global Metabolic Disorders Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Zealand Pharma
• Rhythm
• OxThera
• Biophytis
• Biophytis
• Zafgen
• PerkinElmer
• Eternygen
• Pronutria Biosciences
• MedGenome
• CellCentric
• Nimbus Therapeutics
• Mitobridge
• Exelixis, Inc.
• Outpost Medicine
• Anchor Therapeutics
• Verva Pharmaceuticals

Key Types

• Tablet
• Injection

Key End-Use

• Diabetes
• Disorders of the Thyroid and Pituitary Gland
• Others

This report can be dispatched within 24-48 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaMetabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Table America Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Metabolic Disorders Drugs Production Forecast
Figure Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Metabolic Disorders Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Metabolic Disorders Drugs Forecast by Type
Table Global Metabolic Disorders Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Metabolic Disorders Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Metabolic Disorders Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Metabolic Disorders Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Metabolic Disorders Drugs Forecast by End-Use (2020E-2025F)
Table Global Metabolic Disorders Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Metabolic Disorders Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Metabolic Disorders Drugs Forecast by Region (2020E-2025F)
Table Global Metabolic Disorders Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Metabolic Disorders Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Metabolic Disorders Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Zealand Pharma
  9.1.1 Zealand Pharma Profile
Table Zealand Pharma Overview List
  9.1.2 Zealand Pharma Products & Services
  9.1.3 Zealand Pharma Company Dynamics & News
  9.1.4 Zealand Pharma Business Operation Conditions
Table Business Operation of Zealand Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Rhythm
  9.2.1 Rhythm Profile
Table Rhythm Overview List
  9.2.2 Rhythm Products & Services
  9.2.3 Rhythm Company Dynamics & News
  9.2.4 Rhythm Business Operation Conditions
Table Business Operation of Rhythm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 OxThera
  9.3.1 OxThera Profile
Table OxThera Overview List
  9.3.2 OxThera Products & Services
  9.3.3 OxThera Company Dynamics & News
  9.3.4 OxThera Business Operation Conditions
Table Business Operation of OxThera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Biophytis
  9.4.1 Biophytis Profile
Table Biophytis Overview List
  9.4.2 Biophytis Products & Services
  9.4.3 Biophytis Company Dynamics & News
  9.4.4 Biophytis Business Operation Conditions
Table Business Operation of Biophytis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Biophytis
  9.5.1 Biophytis Profile
Table Biophytis Overview List
  9.5.2 Biophytis Products & Services
  9.5.3 Biophytis Company Dynamics & News
  9.5.4 Biophytis Business Operation Conditions
Table Business Operation of Biophytis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Zafgen
  9.6.1 Zafgen Profile
Table Zafgen Overview List
  9.6.2 Zafgen Products & Services
  9.6.3 Zafgen Company Dynamics & News
  9.6.4 Zafgen Business Operation Conditions
Table Business Operation of Zafgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 PerkinElmer
  9.7.1 PerkinElmer Profile
Table PerkinElmer Overview List
  9.7.2 PerkinElmer Products & Services
  9.7.3 PerkinElmer Company Dynamics & News
  9.7.4 PerkinElmer Business Operation Conditions
Table Business Operation of PerkinElmer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Eternygen
  9.8.1 Eternygen Profile
Table Eternygen Overview List
  9.8.2 Eternygen Products & Services
  9.8.3 Eternygen Company Dynamics & News
  9.8.4 Eternygen Business Operation Conditions
Table Business Operation of Eternygen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Pronutria Biosciences
  9.9.1 Pronutria Biosciences Profile
Table Pronutria Biosciences Overview List
  9.9.2 Pronutria Biosciences Products & Services
  9.9.3 Pronutria Biosciences Company Dynamics & News
  9.9.4 Pronutria Biosciences Business Operation Conditions
Table Business Operation of Pronutria Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 MedGenome
  9.10.1 MedGenome Profile
Table MedGenome Overview List
  9.10.2 MedGenome Products & Services
  9.10.3 MedGenome Company Dynamics & News
  9.10.4 MedGenome Business Operation Conditions
Table Business Operation of MedGenome (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 CellCentric
  9.11.1 CellCentric Profile
Table CellCentric Overview List
  9.11.2 CellCentric Products & Services
  9.11.3 CellCentric Company Dynamics & News
  9.11.4 CellCentric Business Operation Conditions
Table Business Operation of CellCentric (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Nimbus Therapeutics
  9.12.1 Nimbus Therapeutics Profile
Table Nimbus Therapeutics Overview List
  9.12.2 Nimbus Therapeutics Products & Services
  9.12.3 Nimbus Therapeutics Company Dynamics & News
  9.12.4 Nimbus Therapeutics Business Operation Conditions
Table Business Operation of Nimbus Therapeutics (Sales Revenue, Cost, Gross Margin)
9.13 Mitobridge
  9.13.1 Mitobridge Profile
Table Mitobridge Overview List
  9.13.2 Mitobridge Products & Services
  9.13.3 Mitobridge Company Dynamics & News
  9.13.4 Mitobridge Business Operation Conditions
Table Business Operation of Mitobridge (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Exelixis, Inc.
  9.14.1 Exelixis, Inc. Profile
Table Exelixis, Inc. Overview List
  9.14.2 Exelixis, Inc. Products & Services
  9.14.3 Exelixis, Inc. Company Dynamics & News
  9.14.4 Exelixis, Inc. Business Operation Conditions
Table Business Operation of Exelixis, Inc. (Sales Revenue, Cost, Gross Margin)
9.15 Outpost Medicine
  9.15.1 Outpost Medicine Profile
Table Outpost Medicine Overview List
  9.15.2 Outpost Medicine Products & Services
  9.15.3 Outpost Medicine Company Dynamics & News
  9.15.4 Outpost Medicine Business Operation Conditions
Table Business Operation of Outpost Medicine (Sales Revenue, Cost, Gross Margin)
9.16 Anchor Therapeutics
  9.16.1 Anchor Therapeutics Profile
Table Anchor Therapeutics Overview List
  9.16.2 Anchor Therapeutics Products & Services
  9.16.3 Anchor Therapeutics Company Dynamics & News
  9.16.4 Anchor Therapeutics Business Operation Conditions
Table Business Operation of Anchor Therapeutics (Sales Revenue, Cost, Gross Margin)
9.17 Verva Pharmaceuticals
  9.17.1 Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Overview List
  9.17.2 Verva Pharmaceuticals Products & Services
  9.17.3 Verva Pharmaceuticals Company Dynamics & News
  9.17.4 Verva Pharmaceuticals Business Operation Conditions
Table Business Operation of Verva Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Metabolic Disorders Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Metabolic Disorders Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Metabolic Disorders Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Metabolic Disorders Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Metabolic Disorders Drugs Market Concentration Ratio in 2020E
Figure America Metabolic Disorders Drugs Market Concentration Ratio in 2020E
Figure Asia Metabolic Disorders Drugs Market Concentration Ratio in 2020E
Figure Oceania Metabolic Disorders Drugs Market Concentration Ratio in 2020E
Figure Africa Metabolic Disorders Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON METABOLIC DISORDERS DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 METABOLIC DISORDERS DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Metabolic Disorders Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Metabolic Disorders Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Metabolic Disorders Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Metabolic Disorders Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Metabolic Disorders Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Metabolic Disorders Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Metabolic Disorders Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Metabolic Disorders Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Metabolic Disorders Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Metabolic Disorders Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Metabolic Disorders Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Metabolic Disorders Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Metabolic Disorders Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Zealand Pharma Overview List
Table Business Operation of Zealand Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Rhythm Overview List
Table Business Operation of Rhythm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table OxThera Overview List
Table Business Operation of OxThera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biophytis Overview List
Table Business Operation of Biophytis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biophytis Overview List
Table Business Operation of Biophytis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Zafgen Overview List
Table Business Operation of Zafgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table PerkinElmer Overview List
Table Business Operation of PerkinElmer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eternygen Overview List
Table Business Operation of Eternygen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pronutria Biosciences Overview List
Table Business Operation of Pronutria Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedGenome Overview List
Table Business Operation of MedGenome (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CellCentric Overview List
Table Business Operation of CellCentric (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Nimbus Therapeutics Overview List
Table Business Operation of Nimbus Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Mitobridge Overview List
Table Business Operation of Mitobridge (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Exelixis, Inc. Overview List
Table Business Operation of Exelixis, Inc. (Sales Revenue, Cost, Gross Margin)
Table Outpost Medicine Overview List
Table Business Operation of Outpost Medicine (Sales Revenue, Cost, Gross Margin)
Table Anchor Therapeutics Overview List
Table Business Operation of Anchor Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Verva Pharmaceuticals Overview List
Table Business Operation of Verva Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Global Metabolic Disorders Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Metabolic Disorders Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Metabolic Disorders Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Metabolic Disorders Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaMetabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Metabolic Disorders Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Metabolic Disorders Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Metabolic Disorders Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Metabolic Disorders Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Metabolic Disorders Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Metabolic Disorders Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Metabolic Disorders Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Metabolic Disorders Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Metabolic Disorders Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Metabolic Disorders Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Metabolic Disorders Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Metabolic Disorders Drugs Consumption Volume Share by Region in 2025 (Volume)